R.Al-HuseiniI.SakrH.MoqadassM.DasS.JulianaN.et al (2022)
One pathway (GLP-1) handles the incretin response, while the other pathway (amylin) handles the satiety response
Capsules may feel easier because they do not require injections, but safety still depends on product quality, dose, health history, medications, and medical supervision
brain and cellular membranes.* It has also been proposed to be involved
SS-31 (elamipretide), a mitochondria-targeting tetrapeptide that binds cardiolipin, improves mitochondrial structure and bioenergetics, and has shown efficacy in clinical trials for heart failure, ischemia-reperfusion injury, and mitochondrial myopathies ( It should be noted that the current evidence supporting mtROS-targeted interventions is predominantly derived from cellular and animal models, with relatively limited validation in rotator cuff-specific injury models and clinical settings